EUFEP – The European Forum for Evidence-based Health Promotion and Prevention – is an international platform for best practice in evidence based prevention programs.

The goal of EUFEP is to provide a platform for international experts to discuss and debate the challenges of implementing and evaluating population-based prevention programs.

EUFEP was founded and initiated by Mag. Wolfgang Sobotka, Vice-Governor of the province of Lower Austria.

New Dates for EUFEP Congress 2013 are fixed!

Obesity Prevention

From June 12 – 13, 2013, Krems an der Donau will once more be the venue for the “European Forum for Evidence-Based Prevention [EUFEP]“. The internationally renowned symposium will take place for the 4th time and focus on obesity.

 

In the course of the international symposium global as well as national strategies on obesity prevention will be presented, prevention measures evaluated and economic aspects of overweight and obesity discussed.

 

In the 21st century, overweight and obesity are among the greatest challenges to health. They are significant risk factors for diabetes, cardiovascular diseases, muscular and skeletal disorders and carcinomas. According to WHO (the World Health Organization), overweight and obesity are the fifth most common cause of mortality worldwide. Every year, 2.8 million adults die of their consequences. In 2008, as reported by WHO, more than 1.4 billion adults were overweight, of whom 200 million were obese men and almost 300 million were obese women. In Europe, the figure amounts to 20% of the adult population, a third of which is obese. But it is not only in affluent societies that the number of overweight or obese people is increasing, similar developments are also found in developing countries. Should the present forecasts be correct, the majority of the global population  will be overweight or even obese by 2030. (Rokholm, Baker & Sorensen, 2010).

In the US, overweight and obesity are the second most common cause of avoidable diseases and death (Wang & Lobstein, 2008). This enormous disease load burdens society with high additional cost. The annual financial burden is estimated to amount to US$ 290 billion in the US and to € 10 billion in Germany. These amounts include medical cost but also cost of invalidity and lost productivity. The enormous cost to society make the so-called “obesity epidemic” a high-priority public health issue, a challenge that needs to be met by 21st century health policies.

Download

Please download our SAVE THE DATE.